Clinical trial
Metastatic Gastric Cancer FFCD 03-07
NCT00374036 · University Hospital, Toulouse, Other · Completed
Key facts
| NCT number | NCT00374036 |
|---|---|
| Title | Metastatic Gastric Cancer FFCD 03-07 |
| Official title | Strategy Phase III Intergroup Study for Chemotherapy of the Metastatic or Locally Advanced Cancers of the Stomach |
| Lead sponsor | University Hospital, Toulouse, Other |
| Collaborators | Federation Francophone de Cancerologie Digestive Roche Pharma AG Industry Pfizer |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stomach Cancer, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | ECC, FOLFIRI |
| Enrollment | 416 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 8, 2006 |
| Last update posted | Oct 12, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: